Cargando...
Molecular and clinical characterization of Galectin‐9 in glioma through 1,027 samples
In recent years, research on glioma immunotherapy have grown rapidly. However, the autoimmune‐like side effects that are caused by blocking immunological checkpoints hinder their clinical application in gliomas currently. Galectin‐9, a ligand for T‐cell immunoglobulin mucin 3, has shed a new light o...
Guardado en:
| Publicado en: | J Cell Physiol |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7028024/ https://ncbi.nlm.nih.gov/pubmed/31609000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcp.29309 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|